Research Analysts Issue Forecasts for Cibus Q1 Earnings

Cibus, Inc. (NASDAQ:CBUS - Free Report) - Analysts at HC Wainwright issued their Q1 2025 EPS estimates for Cibus in a research note issued to investors on Friday, March 21st. HC Wainwright analyst A. Dayal expects that the company will post earnings of ($0.66) per share for the quarter. HC Wainwright has a "Buy" rating and a $25.00 price objective on the stock. The consensus estimate for Cibus' current full-year earnings is ($2.96) per share. HC Wainwright also issued estimates for Cibus' Q2 2025 earnings at ($0.67) EPS, Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.70) EPS and FY2029 earnings at $1.36 EPS.

Cibus (NASDAQ:CBUS - Get Free Report) last posted its earnings results on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing the consensus estimate of ($0.68) by ($0.19). Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. The business had revenue of $1.21 million for the quarter, compared to analyst estimates of $1.13 million.

Separately, Canaccord Genuity Group lowered their price target on Cibus from $20.00 to $18.00 and set a "buy" rating on the stock in a report on Wednesday, January 22nd.

Cibus Stock Performance

Shares of NASDAQ CBUS traded down $0.12 during mid-day trading on Monday, reaching $2.09. 83,518 shares of the company traded hands, compared to its average volume of 166,770. The company's fifty day moving average is $2.33 and its two-hundred day moving average is $3.30. Cibus has a fifty-two week low of $1.80 and a fifty-two week high of $23.18. The stock has a market cap of $55.16 million, a PE ratio of -0.09 and a beta of 2.04.

Remove Ads

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in CBUS. Charles Schwab Investment Management Inc. grew its position in Cibus by 14.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company's stock worth $161,000 after buying an additional 6,276 shares in the last quarter. FMR LLC grew its holdings in shares of Cibus by 16.9% during the 3rd quarter. FMR LLC now owns 3,913,279 shares of the company's stock worth $12,757,000 after purchasing an additional 566,328 shares in the last quarter. Swan Global Investments LLC bought a new stake in shares of Cibus during the third quarter valued at approximately $115,000. HighTower Advisors LLC raised its stake in shares of Cibus by 20.6% in the third quarter. HighTower Advisors LLC now owns 16,125 shares of the company's stock valued at $52,000 after purchasing an additional 2,750 shares in the last quarter. Finally, State Street Corp lifted its position in Cibus by 43.6% in the third quarter. State Street Corp now owns 307,262 shares of the company's stock worth $1,002,000 after purchasing an additional 93,236 shares during the period. 33.81% of the stock is owned by institutional investors.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.